Sanxin Medical (300453.SZ) announced that recently, Jiangxi Colevide Biotechnology Co., Ltd., a holding subsidiary of the company...
Zhitong Finance App News, Sanxin Medical (300453.SZ) announced that recently, Jiangxi Colectin Biotechnology Co., Ltd. (hereinafter referred to as “colevipid”), the holding subsidiary of the company, received the “Jiangxi Province Class II Medical Device Innovative Product Registration Review Results Form” issued by the Jiangxi Drug Administration. A product “hemorrhage monitor” independently developed by Colectin was approved for registration of Class II medical device innovation products in Jiangxi Province.
According to reports, this product is used to monitor and alarm blood leakage at the patient's puncture site. It can promptly detect bleeding at the puncture point and internal fistula needle slipping during hemodialysis, reduce the probability of medical accidents, improve hemodialysis safety and patient satisfaction, and has remarkable clinical application value.